Global Epinephrine Autoinjector Market 2017-2021

エピペンの世界市場2017-2021

◆タイトル:Global Epinephrine Autoinjector Market 2017-2021
◆商品コード:IRTNTR12027
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年2月17日
◆ページ数:84
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:世界
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、エピペンの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、エピペンの世界市場規模及び予測、需要先別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About epinephrine autoinjectorEpinephrine is among the first line of treatment drugs for anaphylactic conditions and is considered a life-saving drug during emergencies. Epinephrine autoinjectors have proved to be a life savior for people with severe allergies from as early as the 1980s. The global epinephrine autoinjector market has been witnessing continuous technological innovations and developments over the years, after the first FDA approval of EpiPen in 1987.

Technavio’s analysts forecast the global epinephrine autoinjector market to grow at a CAGR of 14.58% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global epinephrine autoinjector market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various epinephrine autoinjectors to key end-users such as hospitals, clinics, and individuals.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Epinephrine Autoinjector Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• ALK-Abelló
• Impax Laboratories
• Lincoln Medical
• Mylan

[Other prominent vendors]
• Adamis Pharmaceuticals
• Antares Pharma
• Emerade
• Hospira
• Kaleo Pharma
• Teva Pharmaceutical Industries

[Market driver]
• Increasing prevalence of allergies
• For a full, detailed list, view our report

[Market challenge]
• Product recalls and regulatory issues
• For a full, detailed list, view our report

[Market trend]
• Tentative product launches
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents

PART 01: Executive summary

PART 02: Scope of  the report

Market overview
Top-vendor offerings

PART 03: Market research methodology

Research methodology
Economic indicators

PART 04: Introduction

Key market highlights
Epinephrine autoinjector: Overview

PART 05: Market landscape

Market overview
Market size and forecast
Five forces analysis

PART 06: Market segmentation by dosage

Global epinephrine autoinjector market by 0.15gm dosage
Global epinephrine autoinjector market by 0.30gm dosage
Global epinephrine autoinjector market by 0.5gm dosage

PART 07: Market segmentation by age group

PART 08: Market segmentation by end-user

Hospitals and clinics
Individuals

PART 09: Geographical segmentation

Epinephrine autoinjector market in the Americas
Epinephrine autoinjector market in EMEA
Epinephrine autoinjector market in APAC

PART 10: Market drivers

Increasing prevalence of allergies
Technological advances
Marketing strategies

PART 11: Impact of drivers

PART 12: Market challenges

Product recalls and regulatory issues
Presence of substitutes
High cost

PART 13: Impact of drivers and challenges

PART 14: Market trends

Tentative product launches
Growing awareness about epinephrine autoinjectors
Patient assistance programs

PART 15: Vendor landscape

Competitive scenario
Key news
Geographical presence of key vendors

PART 16: Key vendor analysis

ALK-Abelló
Impax Laboratories
Lincoln Medical
Mylan
Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings

Exhibit 02: Global epinephrine autoinjector market: Analysis

Exhibit 03: Key buying criteria for epinephrine autoinjectors

Exhibit 04: Buying criteria for epinephrine autoinjectors

Exhibit 05: Key factors influencing development of epinephrine autoinjectors

Exhibit 06: Allergy statistics

Exhibit 07: Market overview: Global epinephrine autoinjector market

Exhibit 08: Global epinephrine autoinjector market ($ millions)

Exhibit 09: Global epinephrine autoinjector market analysis: Developed and developing markets

Exhibit 10: Five forces analysis

Exhibit 11: Global epinephrine autoinjector market segmentation by dosage 2016

Exhibit 12: Global epinephrine autoinjector market segmentation by dosage 2020

Exhibit 13: Global epinephrine autoinjector market by 0.15gm dosage 2016-2021 ($ millions)

Exhibit 14: Global epinephrine autoinjector market by 0.30gm dosage 2016-2021 ($ millions)

Exhibit 15: Global epinephrine autoinjector market by 0.5gm dosage 2016-2021 ($ millions)

Exhibit 16: Global epinephrine autoinjector market segmentation by dosage 2016-2021 (%)

Exhibit 17: Global epinephrine autoinjector market segmentation by dosage 2016-2021 ($ millions)

Exhibit 18: Global epinephrine autoinjector market by age group 2016

Exhibit 19: Global epinephrine autoinjector market by end-user 2016

Exhibit 20: Global epinephrine autoinjector market segmentation by geography 2016

Exhibit 21: Global epinephrine autoinjector market segmentation by geography 2021

Exhibit 22: Epinephrine autoinjector market in the Americas 2016-2021 ($ millions)

Exhibit 23: Market overview: Americas

Exhibit 24: Epinephrine autoinjector market overview: US

Exhibit 25: Epinephrine autoinjector market in the US 2016-2021 ($ millions)

Exhibit 26: Market overview: EMEA

Exhibit 27: Epinephrine autoinjector market in EMEA 2016-2021 ($ millions)

Exhibit 28: Market overview: APAC

Exhibit 29: Epinephrine autoinjector market in APAC 2016-2021 ($ millions)

Exhibit 30: Global epinephrine autoinjector market segmentation by geography 2016-2021 ($ millions)

Exhibit 31: Global epinephrine autoinjector market segmentation by geography 2016-2021 (%)

Exhibit 32: Allergy statistics

Exhibit 33: Technological advances

Exhibit 34: Marketing strategies of Mylan

Exhibit 35: Impact of drivers

Exhibit 36: Product recalls

Exhibit 37: Alternatives of epinephrine autoinjectors in the market

Exhibit 38: Impact of drivers and challenges

Exhibit 39: Competitive structure of the global epinephrine autoinjector market

Exhibit 40: Market penetration of various epinephrine autoinjector manufacturers globally (2016)

Exhibit 41: Strategic success factors of companies in global epinephrine autoinjector market 2016

Exhibit 42: Share of vendors in global epinephrine autoinjector market 2016

Exhibit 43: Regional analysis of key vendors

Exhibit 44: Key highlights of ALK-Abelló

Exhibit 45: ALK-Abelló strength assessment

Exhibit 46: ALK-Abelló strategy assessment

Exhibit 47: ALK-Abelló opportunity assessment

Exhibit 48: Key highlights of Impax Laboratories

Exhibit 49: Impax Laboratories strength assessment

Exhibit 50: Impax Laboratories strategy assessment

Exhibit 51: Impax Laboratories opportunity assessment

Exhibit 52: Lincoln Medical strength assessment

Exhibit 53: Lincoln Medical strategy assessment

Exhibit 54: Lincoln Medical opportunity assessment

Exhibit 55: Key highlights of Mylan

Exhibit 56: Mylan strength assessment

Exhibit 57: Mylan strategy assessment

Exhibit 58: Mylan opportunity assessment



【資料のキーワード】

エピペン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[エピペンの世界市場2017-2021] (Global Epinephrine Autoinjector Market 2017-2021 / IRTNTR12027)販売に関する免責事項
[エピペンの世界市場2017-2021] (Global Epinephrine Autoinjector Market 2017-2021 / IRTNTR12027)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆